MedPath

Evaluation of the effect of Dual Follicle Stimulating Hormone(FSH)/Human Chorionic Gonadotropin hormone(HCG) triggering on the success rate ofIntrauterine insemination (IUI) in couples diagnosed with unexplained infertility.

Phase 3
Recruiting
Conditions
Female infertility.
Female infertility, unspecified
N97.9
Registration Number
IRCT20220702055335N2
Lead Sponsor
Vice chancellor for Research,Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

Having an informed consent to participate in the study
Unexplained infertility diagnosis
The health of the uterus structure
Normal pap smear test
Normal sperm analysis
Women between 20 and 38 years old

Exclusion Criteria

Moderate to severe endometriosis
Hyper prolactinemia
Hyperthyroidism
Hypothyroidism
Ovarian Cysts
Kidney and liver failure
Secondary infertility

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate. Timepoint: 28 days after transfer. Method of measurement: Vaginal sonography.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy rate. Timepoint: 14 days after transfer. Method of measurement: BhCG test.
© Copyright 2025. All Rights Reserved by MedPath